| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $226.6M | — |
| R&D Expense | $82.1M | +144.9% |
| SG&A Expense | $19.0M | +58.3% |
| Operating Income | $125.5M | +375.8% |
| Pre-tax Income | $129.6M | +384.2% |
| Income Tax | $31.3M | — |
| Net Income | $98.3M | +314.1% |
| EPS (Basic) | $1.04 | +267.7% |
| EPS (Diluted) | $1.02 | +264.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $286.4M | +19.9% |
| Short-term Investments | $238.8M | — |
| Current Assets | $530.8M | +117.7% |
| Total Assets | $578.3M | +119.7% |
| Current Liabilities | $79.7M | +899.2% |
| Total Liabilities | $91.4M | +1035.6% |
| Stockholders' Equity | $487.0M | +90.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $183.5M | +510.6% |
| Capital Expenditures | $12.8M | +45.0% |
| Investing Cash Flow | -$266.3M | -2925.0% |
| Financing Cash Flow | $130.4M | -53.7% |
| Free Cash Flow | $170.8M | +419.2% |